Journal of Ovarian Research is calling for submissions to our Collection on Nanotechnological Approaches for the Treatment of Ovarian Cancer. For women, gynecological cancer is the most destructive malignancy. Current treatment options include surgery, chemotherapy, hormonal, and radiation therapy; however, there is no effective treatment for advanced-stage, refractory, recurrent, and drug-resistant cases. Drug-delivering nanocarriers can be used to deliver novel therapeutic agents to treat certain gynecological cancers, such as cervical, ovarian, uterine, vaginal, and vulvar. However, the precise cause of this fatal cancer remains unknown. So, understanding the essential components of this diverse group of cancers is necessary. As a result, researchers are looking for strategies to overcome this deadly disease. Targeted therapies have begun to receive recognition as cutting-edge and extremely promising therapeutic approaches. These treatments have the potential to be innovative and effective ways to enhance patients' quality of life, and they could offer hope to medical professionals searching for fresh treatment targets.
For this collection, we welcome you to submit the original research, review articles, and commentaries on the latest progress on the novel and targeted nano-therapy and its underlying mechanism, including the diagnosis and symptoms of ovarian cancer.